You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《异动股》丽珠医药AH股涨逾7%及5.5%齐创纪录高
阿思达克 07-13 11:38
丽珠医药(01513.HK)(000513.SZ)AH股今天齐创纪录高,H股高见41.7元,现造41.5元,续升5.6%,成交增至75万股,涉资3,080万元;其A股高见52.1元人民币,半日收52.01元,涨7.1%,成交达1,333万股。

丽珠本月初表示,截至6月30日止,公司通过集中竞价交易方式累计回购594.61万股A股,每股作价介乎38.95-44.88元人民币,涉及金额2.43亿人民币。公司亦在月初指与德国药品研发商LTS Lohmann Therapie-Systeme AG签署授权合作协议,LTS将授予公司阿塞那平透皮贴剂(用於治疗精神分裂症)某些知识产权下独家,包含特许权使用费及可转授权许可权,而公司需向LTS支付其在开发期间产生所有人工成本,有关费用上限为320万欧元。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account